RCC – Rádio Clube da Covilhã: “Tratar o cancro por tu” initiative in Covilhã on the 7th
The initiative “Tratar o cancro por tu” from Ipatimup will take place in Covilhã.
Category Article
SESARAM: 3rd Edition of the conference series “Tratar o cancro por tu”
On February 22nd, the lecture on Colon Cancer “Diagnosis and Treatment - Colon” was held at the Jesuit College Auditorium in Funchal.
Governo da Madeira: Prevention and promotion of health literacy were the keywords in the lecture “Diagnosis and Treatment of Colon Cancer”
Prevention and promotion of health literacy were the key themes of the lecture on Colon Cancer “Diagnosis and Treatment - Colon,”.
JM Madeira: Thursday filled with culture
The lecture on Colon Cancer will take place at 6:30 PM in the Jesuit College Auditorium.
JM Madeira: Jesuit College hosts a conference on Colon Cancer
Tomorrow, February 22nd, at 6:30 PM, the Jesuit College Auditorium in Funchal will host a talk on Colon Cancer.
Diário de Notícias: The Health Department and Ipatimup are promoting a talk on Colon Cancer
Tomorrow, February 22nd, at 6:30 PM, the Jesuit College Auditorium in Funchal will host a talk on Colon Cancer.
JM Madeira: Ipatimup comes to Funchal for “Tratar o cancro por tu”
The main goals of this series of in-person cancer literacy sessions, titled “Tratar o cancro por tu”, are to discuss scientific advances, the latest therapies.
Funchal Notícias: Sobrinho Simões in Madeira for a conference on colon cancer
The Autonomous Region of Madeira will host a lecture on Colon Cancer - "Diagnosis and Treatment – Colon" on February 22nd at the Jesuit College Auditorium in Funchal.
Governo da Madeira: The Health Department and Ipatimup are promoting a conference on Colon Cancer
The event features Jorge Fernandes, a general surgery specialist from the Madeira Health Service, and renowned Ipatimup experts.
Diário de Notícias: “Tratar o cancro por tu” addresses colon cancer in a talk in Funchal
The Jesuit College will host another talk under the “Tratar o cancro por tu” initiative from the Institute of Pathology and Molecular Immunology of the University of Porto.